Express Scripts 2009 Annual Report Download - page 34

Download and view the complete annual report

Please find page 34 of the 2009 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 108

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108

Express Scripts 2009 Annual Report 32
Mr. McNamee was named Executive Vice President, Operations & Technology in November 2007. He was
elected Senior Vice President, Operations & Technology, with responsibility for Client & Patient Services and Informatio
n
T
ec
h
nology in May 2007. Mr. McNamee joined us and was elected Senior Vice President and Chief Information Officer i
n
February 2005. Prior to joining us, Mr
.
McNamee worked for Misys Healthcare Systems, a health care technolog
y
c
ompany, as President and Gen
e
r
al Manager, Physician Systems, from September 2003 through February 2005.
Ms. Re
y
-
Giraud was named President, International Operations in November 2008. She previously was named
Executive Vice President, Trade Relations & Developing Markets in Novembe
r
2007.
S
he was elected
S
enior
V
ice
Pr
es
i
de
nt
—
Strategy and Busi
n
ess Development in January 2006
.
M
s.
Re
y
-
G
iraud served as
S
enior
V
ice President of
Product Management between December 2003 and January 2006
.
Ms. Elliott was elected Vice President
,
Chi
e
f Accounting Officer and Controller in December 2005. Ms
.
Elli
o
tt
previously served in our Internal Audit Department between February 2002 and December 2005, most recently as Vice
Pr
es
i
de
nt
.
A
v
aila
b
l
e
Inf
o
rmati
o
n
W
e make available through our website (www.expres
s
-
s
cripts.com) access to our annual report on For
m
1
0
-
K
,
quarterly reports on Form 1
0
-
Q, current reports on Form 8
-
K, all amendments to those reports (when applicable), and othe
r
filings with the SEC. Such access is free of charge and is available as soon as reasonably practicable after such informatio
n
i
s filed with the SEC. In addition, the SEC maintains an internet site (www.sec.gov) containing reports, proxy and
i
nformation statements
,
and other informa
t
ion regarding issuers filing electronically with the SEC (which includes us).
I
nformation included on our website is not part of this annual report.
F
orward Looking Statements and Associated Risk
s
Information we have included or incorporated by reference in this Annual Report on Form 10
-
K, and information
which may be contained in our other filings with the SEC and our press releases or other public statements, contain or may
contain forward
-
d
looking statements. These forward
-
looking statements includ
e, among others, statements of our plans,
objectives, expectations (financial or otherwise) or intentions.
Our forward
-
d
d
l
ooking statements involve risks and uncertainties. Our actual results may differ significantly from
those projected or suggested in an
y forward
n
-
d
d
l
ooking statements. We do not undertake any obligation to release publicly
any revisions to such forward
-
l
ooking statements to reflect events or circumstances occurring after the date hereof or to
r
eflect the occurrence of unanticipated events. Factors which might cause such a difference to occur include, but are no
t
limited
to
:
uncertainties associated with our acquisitions, which include integration risks and costs, uncertainties
associated with client retention and repricing of client contracts
,
and uncertainties associated with the
operations of acquired businesses
r
esults in regulatory matters, the adoption of new legislation or regulations (including
new
healthca
r
e
r
eform
proposals
and
i
ncreased costs associated with compliance with new laws and regulations), more aggressive
enforcement of existing legislation or regulations, or a change in the interpretation of existing legislation or
r
egulations
continued pressure on margins resulting from client demands for lower prices or different pricing approaches,
enhanced service offerings and/or higher service levels
costs and uncertainties of adverse results in litigation, including a number of pending class action cases tha
t
challenge certain of our business practices
the possible loss, or adver
se modification of the terms, of contracts with pharmacies in our retail pharmacy
r
r
netwo
r
k
the possible termination
o
r
non
r
enewal
of, or unfavorable modification to, contracts with key clients or
providers, some of which could have a material impact on our
f
inancial results
our leverage and debt service obligations, including the effect of certain covenants in our borrowing
agreements, access to capital and increases in interest rates
our ability to maintain growth rates, or to control operating or capital costs, including the impact of declines in
prescription drug utilization resulting from the current economic environmen
t
competition in the PBM industr
y
r
, and our ability to consummate contract negotiations with prospective clients,
y
y
as well as competition f
rom new competitors offering services that may in whole or in part replace services
f
f
that we now provide to our customers